202808-22-8

Upstream product

• 86265-88-5 3-bromo-4-chloro-benzaldehyde 

Downstream Products

• 868407-14-1 N-(2-chloro-5-{(E)-3-[3-(4-fluorobenzyl)-3,8-diazabicyclo[3.2.1]oct-8-yl]-3-oxopropenyl}-3'-ureido-biphenyl-4-yl)-acetamide 
• 868407-13-0 N-(3'-acetylamino-2-chloro-5-{(E)-3-[3-(4-fluorobenzyl)-3,8-diazabicyclo[3.2.1]oct-8-yl]-3-oxopropenyl}-biphenyl-4-yl)-acetamide 
• 868407-07-2 N-(3'-amino-2-chloro-5-{(E)-3-[3-(4-fluorobenzyl)-3,8-diazabicyclo[3.2.1]oct-8-yl]-3-oxopropenyl}-biphenyl-4-yl)-acetamide 
• 868407-12-9 N-(4-bromo-5-chloro-2-{(E)-3-[3-(4-fluorobenzyl)-3,8-diazabicyclo[3.2.1]oct-8-yl]-3-oxopropenyl}-phenyl)-acetamide 
• 868407-09-4 (E)-3-(5-bromo-4-chloro-2-nitro-phenyl)-acrylic acid 
• 868407-08-3 (E)-3-(5-bromo-4-chloro-2-nitro-phenyl)-acrylic acid methyl ester 

Relevant academic research and scientific papers

Pyrido-phtalazin diones and their use against neurological disorders associated with excitotoxicity and malfunctioning of glutamatergic neurotransmission

Pyridyl-phtalazin diones having the following formula: STR1 wherein R1 and R2 are selected from the group consisting of hydrogen, halogen, and methoxy or wherein R1 and R2 together form methylenedioxy, and pharmaceutically-acceptable salts thereof, and ph